US Stock MarketDetailed Quotes

ADCT ADC Therapeutics

Watchlist
  • 4.830
  • -0.030-0.62%
Close 02/29 16:00 ET
  • 4.840
  • +0.010+0.21%
Post 19:44 ET
389.50MMarket Cap-2215P/E (TTM)

ADC Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)2023/09/30
(Q2)2023/06/30
(Q1)2023/03/31
(FY)2022/12/31
(Q4)2022/12/31
(Q3)2022/09/30
(Q2)2022/06/30
(Q1)2022/03/31
(FY)2021/12/31
(Q4)2021/12/31
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-1,649.75%-34.02M
30.53%-36.83M
56.40%-14.77M
41.39%-136.79M
15.47%-52.1M
103.75%2.2M
8.62%-53.01M
38.56%-33.88M
-38.32%-233.38M
-19.22%-61.63M
Net income from continuing operations
5.53%-47.81M
26.81%-47.12M
-256.68%-59.43M
32.27%-155.8M
29.74%-24.16M
29.27%-50.61M
11.29%-64.37M
67.67%-16.66M
6.60%-230.03M
38.53%-34.38M
Operating gains losses
-97.65%756K
-51.47%858K
-95.66%109K
516.35%37.73M
-46.73%1.22M
1,351.94%32.23M
28.58%1.77M
968.51%2.51M
125.92%6.12M
109.59%2.29M
Depreciation and amortization
38.64%793K
31.23%769K
16.84%694K
-11.48%2.33M
-24.11%576K
-13.07%572K
-7.72%586K
2.77%594K
33.37%2.63M
25.87%759K
Deferred tax
-231.07%-578K
-74.53%-7.22M
78.01%-848K
97.28%-708K
126.27%6.84M
--441K
---4.14M
---3.86M
---26.05M
-12,859.70%-26.05M
Other non cash items
-42.75%8.3M
233.81%12.01M
111.85%3.1M
-4.87%-17.89M
129.72%2.79M
30.12%14.49M
-2,395.40%-8.98M
-36.38%-26.19M
-134.52%-17.06M
-582.76%-9.38M
Change In working capital
104.82%224K
-98.48%251K
2,267.31%33.62M
-110.12%-33.01M
-686.66%-43.28M
66.05%-4.65M
853.36%16.47M
-187.93%-1.55M
-223.81%-15.71M
-153.80%-5.5M
-Change in receivables
211.53%2.7M
-96.81%188K
1,310.88%48.9M
-41.48%-42.75M
-246.94%-49.69M
82.49%-2.42M
383.26%5.89M
--3.47M
---30.22M
---14.32M
-Change in inventory
-77.19%-3.3M
51.52%-1.9M
50.70%-175K
-196.62%-8.96M
-36.65%-2.82M
-26,714.29%-1.86M
-306.52%-3.93M
---355K
---3.02M
---2.06M
-Change in payables and accrued expense
-74.59%849K
132.26%1.1M
-183.57%-3.66M
5.65%20.41M
64.83%16.1M
93.79%3.34M
-278.50%-3.41M
-25.89%4.38M
14.52%19.32M
-33.42%9.77M
-Change in other current assets
61.55%-1.27M
-87.06%629K
105.16%55K
44.16%-3.55M
-36.37%-4.04M
-88.06%-3.31M
279.34%4.86M
-199.07%-1.07M
-41.09%-6.36M
-636.41%-2.96M
-Change in other current liabilities
-55.37%2.44M
-103.73%-368K
-13.35%-12.09M
----
----
--5.47M
--9.88M
-100.04%-10.67M
----
----
-Change in other working capital
----
-81.02%605K
-78.15%587K
-59.56%1.85M
----
----
1,228.33%3.19M
2,410.28%2.69M
1,297.55%4.57M
--4.08M
Cash from discontinued investing activities
Operating cash flow
-1,649.75%-34.02M
30.53%-36.83M
56.40%-14.77M
41.39%-136.79M
15.47%-52.1M
103.75%2.2M
8.62%-53.01M
38.56%-33.88M
-38.32%-233.38M
-19.22%-61.63M
Investing cash flow
Cash flow from continuing investing activities
-160.24%-661K
-46.88%-1.01M
29.83%-1.02M
62.42%-2.51M
85.90%-117K
89.14%-254K
75.81%-689K
-120.40%-1.45M
-135.96%-6.67M
-4.67%-830K
Net PPE purchase and sale
-241.24%-662K
-2,324.00%-1.21M
-334.93%-996K
83.18%-577K
75.24%-104K
86.19%-194K
94.73%-50K
65.14%-229K
-328.21%-3.43M
-141.38%-420K
Net intangibles purchase and sale
101.67%1K
--0
97.75%-20K
41.58%-1.72M
88.50%-13K
93.57%-60K
60.05%-759K
---889K
-46.71%-2.95M
81.17%-113K
Net other investing changes
--0
----
----
29.29%-210K
--0
--0
--120K
---330K
-1,463.16%-297K
----
Cash from discontinued investing activities
Investing cash flow
-160.24%-661K
-46.88%-1.01M
29.83%-1.02M
62.42%-2.51M
85.90%-117K
89.14%-254K
75.81%-689K
-120.40%-1.45M
-135.96%-6.67M
-4.67%-830K
Financing cash flow
Cash flow from continuing financing activities
-197.55%-2.31M
29,758.33%74.74M
24.03%-196K
-100.22%-593K
-100.99%-2.45M
-98.92%2.37M
-100.51%-252K
13.13%-258K
-45.98%267.39M
57.58%-1.22M
Net issuance payments of debt
-100.36%-409K
-3.57%-261K
24.03%-196K
129.98%111.8M
-735.93%-1.93M
49,987.77%114.24M
-100.51%-252K
14.00%-258K
-21.28%48.61M
-7.44%-231K
Net common stock issuance
----
----
----
--5.91M
---283K
----
----
----
--0
--0
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
1,340.74%778K
385.19%262K
Net other financing activities
---1.9M
----
----
-154.27%-118.3M
81.27%-234K
----
----
----
--218M
---1.25M
Cash from discontinued financing activities
Financing cash flow
-197.55%-2.31M
29,758.33%74.74M
24.03%-196K
-100.22%-593K
-100.99%-2.45M
-98.92%2.37M
-100.51%-252K
13.13%-258K
-45.98%267.39M
57.58%-1.22M
Net cash flow
Beginning cash position
-7.77%347.51M
-27.93%310.55M
-30.03%326.44M
6.23%466.54M
-28.17%380.86M
1.32%376.78M
12.46%430.87M
6.23%466.54M
280.09%439.2M
7.24%530.19M
Current changes in cash
-958.92%-36.99M
168.40%36.9M
55.09%-15.98M
-611.63%-139.9M
14.16%-54.66M
-97.28%4.31M
-379.44%-53.95M
36.57%-35.59M
-91.55%27.34M
-15.03%-63.68M
Effect of exchange rate changes
47.32%-118K
142.07%61K
208.54%89K
-3,566.67%-208K
737.93%243K
-229.41%-224K
-1,066.67%-145K
-373.33%-82K
-97.45%6K
-78.83%29K
End cash Position
-18.50%310.41M
-7.77%347.51M
-27.93%310.55M
-30.03%326.44M
-30.03%326.44M
-28.17%380.86M
1.32%376.78M
12.46%430.87M
6.23%466.54M
6.23%466.54M
Free cash flow
-1,886.60%-34.68M
29.32%-38.04M
54.89%-15.79M
41.99%-139.09M
16.01%-52.21M
103.19%1.94M
11.57%-53.82M
37.28%-35M
-39.77%-239.75M
-18.48%-62.16M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)2023/09/30(Q2)2023/06/30(Q1)2023/03/31(FY)2022/12/31(Q4)2022/12/31(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -1,649.75%-34.02M30.53%-36.83M56.40%-14.77M41.39%-136.79M15.47%-52.1M103.75%2.2M8.62%-53.01M38.56%-33.88M-38.32%-233.38M-19.22%-61.63M
Net income from continuing operations 5.53%-47.81M26.81%-47.12M-256.68%-59.43M32.27%-155.8M29.74%-24.16M29.27%-50.61M11.29%-64.37M67.67%-16.66M6.60%-230.03M38.53%-34.38M
Operating gains losses -97.65%756K-51.47%858K-95.66%109K516.35%37.73M-46.73%1.22M1,351.94%32.23M28.58%1.77M968.51%2.51M125.92%6.12M109.59%2.29M
Depreciation and amortization 38.64%793K31.23%769K16.84%694K-11.48%2.33M-24.11%576K-13.07%572K-7.72%586K2.77%594K33.37%2.63M25.87%759K
Deferred tax -231.07%-578K-74.53%-7.22M78.01%-848K97.28%-708K126.27%6.84M--441K---4.14M---3.86M---26.05M-12,859.70%-26.05M
Other non cash items -42.75%8.3M233.81%12.01M111.85%3.1M-4.87%-17.89M129.72%2.79M30.12%14.49M-2,395.40%-8.98M-36.38%-26.19M-134.52%-17.06M-582.76%-9.38M
Change In working capital 104.82%224K-98.48%251K2,267.31%33.62M-110.12%-33.01M-686.66%-43.28M66.05%-4.65M853.36%16.47M-187.93%-1.55M-223.81%-15.71M-153.80%-5.5M
-Change in receivables 211.53%2.7M-96.81%188K1,310.88%48.9M-41.48%-42.75M-246.94%-49.69M82.49%-2.42M383.26%5.89M--3.47M---30.22M---14.32M
-Change in inventory -77.19%-3.3M51.52%-1.9M50.70%-175K-196.62%-8.96M-36.65%-2.82M-26,714.29%-1.86M-306.52%-3.93M---355K---3.02M---2.06M
-Change in payables and accrued expense -74.59%849K132.26%1.1M-183.57%-3.66M5.65%20.41M64.83%16.1M93.79%3.34M-278.50%-3.41M-25.89%4.38M14.52%19.32M-33.42%9.77M
-Change in other current assets 61.55%-1.27M-87.06%629K105.16%55K44.16%-3.55M-36.37%-4.04M-88.06%-3.31M279.34%4.86M-199.07%-1.07M-41.09%-6.36M-636.41%-2.96M
-Change in other current liabilities -55.37%2.44M-103.73%-368K-13.35%-12.09M----------5.47M--9.88M-100.04%-10.67M--------
-Change in other working capital -----81.02%605K-78.15%587K-59.56%1.85M--------1,228.33%3.19M2,410.28%2.69M1,297.55%4.57M--4.08M
Cash from discontinued investing activities
Operating cash flow -1,649.75%-34.02M30.53%-36.83M56.40%-14.77M41.39%-136.79M15.47%-52.1M103.75%2.2M8.62%-53.01M38.56%-33.88M-38.32%-233.38M-19.22%-61.63M
Investing cash flow
Cash flow from continuing investing activities -160.24%-661K-46.88%-1.01M29.83%-1.02M62.42%-2.51M85.90%-117K89.14%-254K75.81%-689K-120.40%-1.45M-135.96%-6.67M-4.67%-830K
Net PPE purchase and sale -241.24%-662K-2,324.00%-1.21M-334.93%-996K83.18%-577K75.24%-104K86.19%-194K94.73%-50K65.14%-229K-328.21%-3.43M-141.38%-420K
Net intangibles purchase and sale 101.67%1K--097.75%-20K41.58%-1.72M88.50%-13K93.57%-60K60.05%-759K---889K-46.71%-2.95M81.17%-113K
Net other investing changes --0--------29.29%-210K--0--0--120K---330K-1,463.16%-297K----
Cash from discontinued investing activities
Investing cash flow -160.24%-661K-46.88%-1.01M29.83%-1.02M62.42%-2.51M85.90%-117K89.14%-254K75.81%-689K-120.40%-1.45M-135.96%-6.67M-4.67%-830K
Financing cash flow
Cash flow from continuing financing activities -197.55%-2.31M29,758.33%74.74M24.03%-196K-100.22%-593K-100.99%-2.45M-98.92%2.37M-100.51%-252K13.13%-258K-45.98%267.39M57.58%-1.22M
Net issuance payments of debt -100.36%-409K-3.57%-261K24.03%-196K129.98%111.8M-735.93%-1.93M49,987.77%114.24M-100.51%-252K14.00%-258K-21.28%48.61M-7.44%-231K
Net common stock issuance --------------5.91M---283K--------------0--0
Proceeds from stock option exercised by employees --------------0----------------1,340.74%778K385.19%262K
Net other financing activities ---1.9M---------154.27%-118.3M81.27%-234K--------------218M---1.25M
Cash from discontinued financing activities
Financing cash flow -197.55%-2.31M29,758.33%74.74M24.03%-196K-100.22%-593K-100.99%-2.45M-98.92%2.37M-100.51%-252K13.13%-258K-45.98%267.39M57.58%-1.22M
Net cash flow
Beginning cash position -7.77%347.51M-27.93%310.55M-30.03%326.44M6.23%466.54M-28.17%380.86M1.32%376.78M12.46%430.87M6.23%466.54M280.09%439.2M7.24%530.19M
Current changes in cash -958.92%-36.99M168.40%36.9M55.09%-15.98M-611.63%-139.9M14.16%-54.66M-97.28%4.31M-379.44%-53.95M36.57%-35.59M-91.55%27.34M-15.03%-63.68M
Effect of exchange rate changes 47.32%-118K142.07%61K208.54%89K-3,566.67%-208K737.93%243K-229.41%-224K-1,066.67%-145K-373.33%-82K-97.45%6K-78.83%29K
End cash Position -18.50%310.41M-7.77%347.51M-27.93%310.55M-30.03%326.44M-30.03%326.44M-28.17%380.86M1.32%376.78M12.46%430.87M6.23%466.54M6.23%466.54M
Free cash flow -1,886.60%-34.68M29.32%-38.04M54.89%-15.79M41.99%-139.09M16.01%-52.21M103.19%1.94M11.57%-53.82M37.28%-35M-39.77%-239.75M-18.48%-62.16M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg